Skip to main content
. 2019 Sep 3;20(17):4307. doi: 10.3390/ijms20174307

Table 3.

Systematic reviews applying CIK cell and DC cell for the treatment of NSCLC.

Study Reference RCTs (n) Total Patients (n) Total Therapy
Wang et al. (2014) [57] 17 1172 Chemotherapy;
Immunotherapy group: additional CIK cell and DC cell transfusions
Mi et al. (2016) [60] 10 Chemotherapy;
Immunotherapy group: additional CIK cell transfusions and IL-2
Xiao et al. (2018) [64] 16 1197 Radiotherapy;
Immunotherapy group: additional CIK cell and DC cell transfusions
Total 43 2369